VEGFA and Patent ductus arteriosus: Capillary CNV is highly responsive to anti-VEGF therapies and rarely exhibits PDA, whereas high-flow CNV forms lesions with arteriolarization and perivascular fibrosis and thus tends to develop PDA through a mechanism called neovascular remodeling (NVR), in which blood-derived macrophages play an important role [11].